Uploaded August 2026 | Updated September 2026, 1 hour ago
During the third meeting of 2026, the Advisory Council will hear from a panel organized by the research subcommittee; updates from federal agencies, including an overview of the authorities of the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services; legislative updates from advocacy groups; and an update on the Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease (REMIND) Study. Advisory Council subcommittees will also present their recommendations for adoption by the full Advisory Council.
---
U.S. Department of Health and Human Services (HHS)
hhs.gov
HHS Privacy Policy
During the third meeting of 2026, the Advisory Council will hear from a panel organized by the research subcommittee; updates from federal agencies, including an overview of the authorities of the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare & Medicaid Services; legislative updates from advocacy groups; and an update on the Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease (REMIND) Study. Advisory Council subcommittees will also present their recommendations for adoption by the full Advisory Council.
---
U.S. Department of Health and Human Services (HHS)
hhs.gov
HHS Privacy Policy
